Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 survey

Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 survey

<p>Abstract</p> <p>Background</p> <p>Many patients with coronary artery disease (CAD) have overlapping gastroenterological causes of recurrent chest pain, mainly due to gastroesophageal reflux (GER) and aspirin-induced gastrointestinal tract damage. These symptoms can b...

Full description

Bibliographic Details
Main Authors: Kłopocka Maria, Majer Marcin, Fabisiak Jacek, Suppan Karol, Pulkowski Grzegorz, Budzyński Jacek, Galus-Pulkowska Beata, Wasielewski Marcin
Format: Article
Language:English
Published: BMC 2011-09-01
Series:Health and Quality of Life Outcomes
Subjects:
quality of life
SF-36 questionnaire
chest pain
omeprazole
coronary artery disease
Online Access:http://www.hqlo.com/content/9/1/77

Internet

http://www.hqlo.com/content/9/1/77

Similar Items